Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Neoplasms × Receptor Protein-Tyrosine Kinases × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Esophageal Neoplasms 3 Stomach Neoplasms 2 Recurrence 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Solid Tumors Harboring NTRK Fusion 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdomyosarcoma 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Liver Neoplasms 1 Insulin-Like Growth Factor I, Resistance To 1 Gliosarcoma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms 1 Brain Neoplasms 1 Advanced Solid Tumor 1

Interventions

Trastuzumab 527 Paclitaxel 501 Cyclophosphamide 482 Docetaxel 425 Capecitabine 359 Letrozole 312 Fulvestrant 276 Doxorubicin 254 Carboplatin 241 Tamoxifen 227 Anastrozole 189 exemestane 182 Radiotherapy 181 Epirubicin 179 Bevacizumab 172 Vinorelbine 151 Lapatinib 151 Gemcitabine 149 pembrolizumab 145 pertuzumab 143 palbociclib 135 Exercise 116 Albumin-Bound Paclitaxel 107 Magnetic Resonance Spectroscopy 104 Fluorouracil 104 eribulin 99 130-nm albumin-bound paclitaxel 95 Everolimus 90 Taxes 85 Cisplatin 84

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00681993 2019-01-22

PBIC

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡